Step 1 topics → Reproductive → Preeclampsia / Eclampsia / HELLP

Preeclampsia / Eclampsia / HELLP

USMLE Step 1 trap: Confuses magnesium's role as anticonvulsant with antihypertensive therapy. Magnesium sulfate is given solely for seizure prophylaxis and treatment, not as an antihypertensive.

Preeclampsia, eclampsia, and HELLP syndrome are high-yield obstetric emergencies that USMLE Step 1 consistently tests across multiple angles — from pure definition recall to mechanistic reasoning and clinical management decisions. Preeclampsia is new-onset hypertension (≥140/90) with proteinuria or severe features after 20 weeks gestation; eclampsia adds new-onset seizures; HELLP adds Hemolysis, Elevated Liver enzymes, and Low Platelets. These aren't just a list of criteria to memorize — the exam wants you to understand why these things happen and what to do about them.

The pathophysiology question is where students most often lose points. The dominant misconception is treating preeclampsia as a kidney disease or a maternal vascular problem from the start. It isn't. It begins with defective trophoblast invasion of the spiral arteries during placentation, causing placental ischemia, which then drives release of anti-angiogenic factors (particularly sFlt-1) that cause systemic endothelial dysfunction — and that endothelial dysfunction is what produces the hypertension, proteinuria, and end-organ damage. The placenta is the culprit; delivery is the cure.

Management questions on USMLE Step 1 love to test two things: what magnesium sulfate actually does (it is an anticonvulsant, not an antihypertensive — students confuse this constantly), and what magnesium toxicity looks like in order (DTR loss first, then respiratory depression — not the other way around). The HELLP vs. acute fatty liver of pregnancy (AFLP) differential is a classic vignette trap where knowing the unique features of each — hypoglycemia and hyperammonemia belong to AFLP, not HELLP — separates high scorers from the rest.

From real student decks
86%have cards covering this topic
59%have mature cards

Common misconceptions

Common mistake
Wrong: Magnesium sulfate is given in eclampsia to lower blood pressure.
Right: Magnesium sulfate is given solely for seizure prophylaxis and treatment, not as an antihypertensive.
Magnesium sulfate has essentially no clinically meaningful antihypertensive effect at the doses used in obstetrics. Its role is purely as an anticonvulsant — it raises the seizure threshold, likely by blocking NMDA receptors and reducing neuronal excitability. If you see a vignette asking why a patient with eclampsia is receiving magnesium, the answer is seizure prophylaxis or treatment, not blood pressure control. Antihypertensive therapy (labetalol, hydralazine, nifedipine) is a completely separate intervention handled in parallel.
Common mistake
Wrong: The first sign of magnesium toxicity is respiratory depression.
Right: Loss of deep tendon reflexes (patellar reflex) is the earliest sign of magnesium toxicity, preceding respiratory depression.
Magnesium toxicity follows a predictable, testable sequence: loss of deep tendon reflexes (patellar reflex disappears first) → respiratory depression → cardiac arrest. This matters because Step 1 loves to ask what you check at the bedside to monitor for toxicity — the answer is DTRs, not respiratory rate or oxygen saturation as a first sign. If you skip straight to respiratory depression as the earliest warning sign, you'll miss a patient who's already past the safe window. Calcium gluconate reverses toxicity by competitively antagonizing magnesium.
Common mistake
Wrong: Preeclampsia is caused by the mother's kidneys failing to regulate blood pressure.
Right: Preeclampsia originates from abnormal placental implantation causing inadequate trophoblast invasion, leading to placental ischemia and release of anti-angiogenic factors (sFlt-1) that cause systemic endothelial dysfunction.
The kidney is a victim in preeclampsia, not the cause. The disease begins weeks before symptoms appear, with inadequate invasion of maternal spiral arteries by cytotrophoblasts during placentation. This leaves the spiral arteries narrow and high-resistance, causing placental ischemia. The ischemic placenta releases anti-angiogenic factors — most importantly sFlt-1, which sequesters VEGF and PlGF — and this systemic factor deprivation causes widespread endothelial dysfunction. The resulting vascular damage explains every manifestation: hypertension (vasoconstriction), proteinuria (glomerular endotheliosis), thrombocytopenia (endothelial activation consuming platelets), and elevated liver enzymes (hepatic ischemia).
Common mistake
Wrong: HELLP syndrome and acute fatty liver of pregnancy both present with markedly elevated ammonia and coagulopathy.
Right: AFLP characteristically causes hypoglycemia, elevated ammonia, and DIC, whereas HELLP features hemolysis, elevated liver enzymes, and thrombocytopenia without the metabolic derangements of AFLP.
HELLP and AFLP can both cause right upper quadrant pain, elevated liver enzymes, and a sick pregnant patient — but their distinguishing features are specific and high-yield. AFLP is a mitochondrial fatty acid oxidation disorder that causes hepatocyte dysfunction, leading to hypoglycemia (liver can't maintain gluconeogenesis), hyperammonemia (liver can't clear ammonia), and DIC (loss of clotting factor synthesis). HELLP is driven by endothelial dysfunction and microangiopathic hemolysis, so the defining labs are a low platelet count, elevated LDH/schistocytes (hemolysis), and elevated transaminases — without the metabolic derangements. If the vignette mentions hypoglycemia or asterixis, think AFLP.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Knowing the precise diagnostic criteria that distinguish gestational hypertension, preeclampsia, preeclampsia with severe features, eclampsia, and HELLP — including which lab abnormality or symptom pushes a diagnosis into 'severe features' territory.
  2. Understanding the placental origin of preeclampsia: defective trophoblast invasion → spiral artery narrowing → placental ischemia → sFlt-1 release → systemic endothelial dysfunction → hypertension, proteinuria, and end-organ damage.
  3. Applying the management framework: antihypertensives (labetalol, hydralazine, nifedipine) for acute BP control, magnesium sulfate for seizure prophylaxis (not BP), and delivery as definitive treatment — and knowing when to deliver versus expectantly manage.
  4. Recognizing magnesium toxicity by sequence: first sign is loss of deep tendon reflexes (check patellar reflex), then respiratory depression, then cardiac arrest — and knowing that calcium gluconate is the antidote.
  5. Differentiating HELLP syndrome from acute fatty liver of pregnancy (AFLP) using distinguishing lab findings: AFLP uniquely features hypoglycemia, hyperammonemia, and DIC, while HELLP is defined by its triad of hemolysis, elevated liver enzymes, and thrombocytopenia.

Can you avoid these mistakes?

A 32-year-old G2P1 at 36 weeks presents with BP 158/102, headache, and visual changes. Labs show platelets 85,000, LDH 820, AST 110. She is started on IV magnesium sulfate. One hour later, her patellar reflex cannot be elicited. What is the next step, and what drug do you reach for?
A medical student on your team says magnesium sulfate was started to 'control the patient's blood pressure.' How would you correct this, and what is actually used for acute severe hypertension in preeclampsia?
A 28-year-old at 34 weeks develops RUQ pain, nausea, and jaundice. Labs show AST 95, platelets 70,000, LDH 650, glucose 48, ammonia 90 µmol/L, and PT prolonged. Is this more consistent with HELLP or AFLP, and what finding most drives your decision?
Explain in two sentences how a problem with placental implantation in the first trimester eventually causes a patient to present with hypertension and proteinuria at 28 weeks — what is the mechanistic bridge?

Related topics

Maternal Physiologic Adaptations to Pregnancy Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →